References

We acknowledge National Science Centre (SONATA DEC-2012/07/D/NZ1/04244 "Structural studies based on low sequence similarity of G protein-coupled receptors activated by hormones and allosteric modulators").

1. Latek D, Rutkowska E, Niewieczerzal S, Cielecka-Piontek J (2019) Drug-induced diabetes type 2: In silico study involving class B GPCRs. PLoS ONE 14(1): e0208892. https://doi.org/10.1371/journal.pone.0208892

2. Pasznik P, Rutkowska E, Niewieczerzal S, Cielecka-Piontek J, Latek D (2019) Potential off-target effects of beta-blockers on gut hormone receptors: In silico study including GUT-DOCK—A web service for small-molecule docking. PLoS ONE 14(1): e0210705. https://doi.org/10.1371/journal.pone.0210705

3. Mizera, M.; Latek, D. Ligand-Receptor Interactions and Machine Learning in GCGR and GLP-1R Drug Discovery. Int. J. Mol. Sci. 2021, 22, 4060. https://doi.org/10.3390/ijms22084060

4. Langer I, Latek D. Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors. Front Endocrinol (Lausanne). 2021 Nov 18;12:711906. doi: 10.3389/fendo.2021.711906

5. Dragan, P.; Joshi, K.; Atzei, A.; Latek, D. Keras/TensorFlow in Drug Design for Immunity Disorders. Int. J. Mol. Sci. 2023, 24, 15009. https://doi.org/10.3390/ijms241915009

If you are interested in our work, please contact the corresponding author.